Rob Hamilton

[Rob Hamilton @RdgRobH]

@cobraalerts $BULL

[Rob Hamilton @RdgRobH]

@BillBrooklyn10 Stocks

[Rand Paul @RandPaul]

The DOJ's deadline to charge Fauci for lying under oath about funding gain-of-function research in Wuhan is in 6 days. We can’t allow the statute of limitations to run out. He MUST be charged!

Agree? RT.

[Elon Musk @elonmusk]

California legislators are trying to make investigating fraud illegal

[Wound Healing MDs @WoundHealingMDs]

Recent publications highlight the effectiveness of combining laser and plasma therapy for treating chronic diabetic foot ulcers. This dual modality approach shows enhanced results compared to single-therapy protocols.

**Treatment Benefits**:
- Enhanced tissue regeneration
- Improved vascularization
- Reduced inflammation
- Accelerated wound closure

**Clinical Evidence**: Reviewed in recent wound care journal updates as promising adjunctive therapy

**Source**: Wound Market Consulting - February 2026
https://t.co/qbylcWB1oF

[Nicholas Fabiano, MD @NTFabiano]

Pet ownership is associated with a reduced brain age of up to 15 years.

[Wound Healing MDs @WoundHealingMDs]

The type of light you work / sit / live under will ultimately determine your health. Sunlight is best! Circadian rhythms are critical!

[Wound Healing MDs @WoundHealingMDs]

Fascinating. No surprise about the biophotons but this helps explains why humans can survive without so much sunlight in colder environments.... or at least we used to be able to! Now we live in sunless, cold environments in artificially heated blue-lit homes.... explains a lot...

[Wound Healing MDs @WoundHealingMDs]

Excellent article!

[Wound Healing MDs @WoundHealingMDs]

My Daily Wound Care Digest

## 🎯 Key Breakthrough: SkinTE Receives FDA Breakthrough Therapy Designation

**Major Development**: The FDA has granted breakthrough therapy designation to SkinTE (PolarityTE), an autologous heterogeneous skin construct for treating Wagner grade 1 diabetic foot ulcers (DFU). This designation accelerates the development and review of promising therapies for serious conditions.

**Clinical Trial Results**: A phase 2 multi-center randomized controlled trial with 100 patients across 13 sites demonstrated that SkinTE plus standard of care significantly improved wound closure rates at 12 weeks compared to standard care alone. The primary endpoint measured 100% skin regrowth without drainage, confirmed at two visits two weeks apart.

**Impact**: With 18.9 million people worldwide and 1.6 million in the US affected by DFU annually, this represents a significant therapeutic advancement for a condition that currently has limited treatment options.

**Source**: [Pharmacy Times - February 11, 2026](https://t.co/mBOdcsbyBC)

## 🔬 Revolutionary Research: Mitochondrial RNA Discovery

**Breakthrough Finding**: Researchers at Karolinska Institutet have identified a circular RNA in mitochondria, circMTRNR2, that plays a crucial role in chronic wound healing. This molecule was found to be significantly reduced in tissue from patients with long-standing diabetic foot ulcers.

**Mechanism**: The RNA molecule protects skin fibroblasts by stabilizing antioxidants that counteract harmful cellular stress. When circMTRNR2 levels decrease, fibroblast function (growth, migration, and tissue building) is impaired, leading to slower wound healing.

**Research Results**: In both human wound tissue models and animal studies, healing was slower when circMTRNR2 was reduced and faster when levels were increased, suggesting a potential new therapeutic target.

**Publication**: Advanced Science (2026). DOI: 10.1002/advs.202517141

**Source**: [Medical Xpress - February 12, 2026](https://t.co/byw7bkZju3)

## 📈 Market Growth: Wound Care Devices Market Expanding

**Industry Insight**: The global wound care devices market is projected to reach USD 3.64 billion in 2026, driven by increasing chronic disease prevalence and patient mobility needs.

**Key Drivers**:
- Rising instances of chronic diseases
- Growing demand for specialized support surfaces (pressure-relieving mattresses, cushions)
- Advanced wound dressings enhancing treatment efficacy
- Negative pressure wound therapy (NPWT) capturing major market share

**Source**: [Globe Newswire - February 13, 2026](https://t.co/CYPCpxb5c2)

## 🧬 Regenerative Medicine Advances

**New Therapeutic Perspectives**: A comprehensive review published in MDPI highlights major advances in regenerative medicine for diabetic foot ulcer management, including:
- Enhanced VEGF expression promoting endothelial progenitor cell recruitment
- Upregulation of PDGF and FGF-2 supporting angiogenesis
- EGF enhancing keratinocyte proliferation
- TGF-β contributing to tissue regeneration

**Source**: [MDPI - February 8, 2026](https://t.co/OZ03EiMLlC)

## 🏥 Clinical Practice Insights

**Evidence-Based Guidelines**: New research from Frontiers in Endocrinology emphasizes the importance of integrating clinical data into evidence-based practice for diabetic foot infections. Key findings show that cultures were obtained from only 130 of 400 admitted patients with diabetic foot conditions, with 118 yielding positive results, highlighting the need for standardized culture collection protocols.

**Source**: [Frontiers in Endocrinology - February 9, 2026](https://t.co/BZdjtYGmYz)

## 🧪 Advanced Dressings Research

**Future Technologies**: Emerging research published in ScienceDirect explores next-generation clinical dressings for chronic wound repair, including:
- Hydrogels and smart hydrogels
- Advanced scaffolds and nanoparticles
- 3D bioprinting applications
- AI-based treatment tools
- Bioactive compound delivery systems

**Combination Therapies**: Studies show that combining advanced dressings with established clinical approaches like negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT) can significantly enhance treatment efficacy.

**Source**: [ScienceDirect - February 8, 2026](https://t.co/9LAnQglcMz)

## 📊 Prevention Focus

**Daily Inspection Protocol**: Research confirms that compliance with daily foot inspection protocols correlates strongly with reduced amputation rates (p<0.001), emphasizing the critical role of patient education and preventive care.

**Therapeutic Footwear**: Studies highlight that therapeutic footwear is not a luxury but a biomechanical intervention that redistributes plantar pressure and prevents ulcer formation.

---

[Wound Healing MDs @WoundHealingMDs]

Every day we search for the best and newest information and research in wound care. I'm going to post it here so we can learn together!

Here's today's digest:

# Daily Wound Care Digest - February 12, 2026

## 🎯 Major Breakthroughs

### 1. FDA Grants Breakthrough Therapy Designation to SkinTE for Diabetic Foot Ulcers
**Source:** Pharmacy Times (February 11, 2026)
**URL:** https://t.co/mBOdcsbyBC

The FDA has granted breakthrough therapy designation to SkinTE (PolarityTE), a novel autologous heterogeneous skin construct for treating Wagner grade 1 diabetic foot ulcers. In phase 2 trials, 70% of patients receiving SkinTE plus standard care achieved wound closure at 12 weeks, compared to only 34% with standard care alone. The phase 3 trial is 75% enrolled with results expected in Q1 2026.

### 2. Revolutionary Hemastyl System Shows 98% Wound Closure Rate
**Source:** American Journal of Managed Care (February 6, 2026)
**URL:** https://t.co/ZhJYR7CdZC

A feasibility study across 39 patients with chronic diabetic foot ulcers showed remarkable results:
- 98% average wound closure rate
- Rapid microbe reduction within 1-2 days
- All 19 patients facing amputation avoided surgery
- Restored warmth and sensation in many patients

The Hemastyl System represents a fundamental shift by addressing neuropathy directly rather than just managing around it.

## 🔬 Emerging Research

### 3. Scientists Discover Why Some Wounds Refuse to Heal
**Source:** ScienceDaily (January 20, 2026)
**URL:** https://t.co/5BK2JZyQ5o

New research reveals mechanisms behind chronic wound healing failures, offering promising approaches for wounds infected with antibiotic-resistant bacteria.

### 4. Innovative Strategies Against Chronic Infected Wounds
**Source:** Applied Sciences (February 7, 2026)
**URL:** https://t.co/iA1MbzSOFU

Researchers are exploring:
- Hydrogels with enhanced antimicrobial properties
- Photodynamic therapy for infected wounds
- Probiotics to support wound healing
- Phage therapy targeting specific bacteria

### 5. Regenerative Medicine Transforming DFU Management
**Source:** MDPI (February 8, 2026)
**URL:** https://t.co/OZ03EiMLlC

Regenerative therapies combining stem cells, biomaterials, and growth factors are providing lasting solutions for chronic wounds, transforming non-healing wounds into opportunities for effective tissue repair.

## 🌍 Global Innovations

### 6. India Launches Advanced Wound Dressing #ColoNoX
**Source:** DAE India Twitter (February 2026)
**URL:** https://t.co/EV3uidbPX9

India's Department of Atomic Energy and Cologenesis launched ColoNoX, the first advanced wound dressing for diabetic foot ulcers, developed by BARC and validated through clinical trials.

### 7. Silk-Based Collagen Gel for Faster Recovery
**Source:** CSIR India Twitter (February 2026)
**URL:** https://t.co/hZxSLtj4nw

Next-generation collagen hydrogel derived from silk shows particular promise for diabetic ulcers, burns, and chronic wounds requiring long-term management.

## 📊 Clinical Practice Updates

### 8. New Guidelines for Diabetic Foot Infections
**Source:** Frontiers in Endocrinology (February 9, 2026)
**URL:** https://t.co/BZdjtYGmYz

New institutional guidelines emphasize:
- Cultures should be obtained only from clinically infected ulcers
- All diabetic patients are considered immunocompromised
- Early intervention prevents progression to severe infections

### 9. Biafine Enhances Wound Healing Through Macrophage Migration
**Source:** Dermatology Times (February 5, 2026)
**URL:** https://t.co/e2LkeiQ1qa

Biafine topical treatment induces macrophage migration into wound areas, accelerating the healing process.

## 🎯 Key Takeaways for Clinical Practice

1. **Address Neuropathy Directly**: New treatments like Hemastyl show that restoring nerve signaling can enable healing in previously non-responsive wounds.

2. **Early Intervention Critical**: With 18.9 million people worldwide affected by DFUs annually, early treatment prevents progression and amputation.

3. **Regenerative Approaches**: Combining cellular therapies with biomaterials is showing unprecedented success rates.

4. **Microbial Management**: Rapid reduction of microbial burden within 1-2 days is crucial for wound closure success.

5. **Patient Selection**: Wagner grade 1 ulcers show the best response to advanced therapies like SkinTE.

## 🔮 Looking Ahead

- Phase 3 results for SkinTE expected Q1 2026
- Multiple regenerative therapies in pipeline
- Growing emphasis on addressing neuropathy as root cause
- Integration of advanced biomaterials in standard care

---

[Rob Hamilton @RdgRobH]

@TommiPedruzzi Access

[Rob Hamilton @RdgRobH]

@NahFlo2n Health

[Florin @NahFlo2n]

90k–$150k/month doctor-style ai pages grow by triggering curiosity, not flashing credentials

the hook isn’t authority or white coats
it’s soft openers like “most people don’t realize this” or “quick thing nobody talks about”

the avatar feels calm and relatable
the visuals stop the scroll
the explanation stays educational, not salesy

no real doctors
no filming sessions
ai handles faces, scripts, timing, and scale

people save and share first
monetization slides in later

rt + comment “health” and i’ll dm it
(follow for dm)

[Rob Hamilton @RdgRobH]

@Manu_Sisti Start

[Rob Hamilton @RdgRobH]

@reachvaldo How

[Rob Hamilton @RdgRobH]

@heygurisingh Claude

[Rob Hamilton @RdgRobH]

@Zephyr_hg NEWS

[Rob Hamilton @RdgRobH]

@Manu_Sisti Guid

[Gad Saad @GadSaad]

This is unimaginable. The people who do this should receive the same treatment. Those who are cruel to dogs have no souls.